Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Biodexa Pharmaceuticals

    MCap

    USD6m

    Last close

    USD1.30

    ▲ 0.58 (79.31%)

    Pharnext

    MCap

    1m

    Last close

    EUR0.10

    ▲ 0.03 (42.86%)

    MGI – Media and Games Invest

    MCap

    EUR235m

    Last close

    EUR1.50

    ▲ 0.35 (30.21%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

paradigm logo NEW

Paradigm Biopharma (ASX: PAR)

Last close As at 26/04/2024

0.46

▲ 0.02 (4.55%)

Market capitalisation

AUD154m

Latest Insights

View More

Healthcare | Update

Paradigm Biopharmaceuticals — Q1 results recap iPPS progress in OA & MPS

Healthcare | Flash note

Paradigm Biopharma — Disease modifying properties in iPPS Phase II

Healthcare | Update

Paradigm Biopharma — Durable responses observed for kOA

Healthcare | Flash note

Paradigm Biopharma — Progressing toward key near-term objectives
Visit Website

Sector

Healthcare

Balance Sheet

Forecast net debt (A$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 6.3 (26.8) (69.6)
Relative (0.1) (32.6) (72.0)
52 week high/low A$1.5/A$0.4

Financials

Edison Investment Research is terminating coverage on Paradigm Biopharma (PAR). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

 

Previously published reports can still be accessed via our website.

Y/E Jun Revenue (A$m) EBITDA (A$m) PBT (A$m) EPS (fd) (c) P/E (x) P/CF (x)
2022A 0.1 (55.7) (39.2) (16.9) N/A N/A
2023A 0.0 (59.9) (51.9) (21.0) N/A N/A
2024E N/A N/A N/A N/A N/A N/A
2025E N/A N/A N/A N/A N/A N/A